Neimeth International Pharmaceuticals Plc kicked off 2025 with outstanding Q1 results, as surging demand in its pharmaceutical and animal‐health divisionsread more Neimeth’s revenue jumps 86% on pharma, animal‐health revival
Related Articles
Don't miss out on breaking stories and in-depth articles.